Clinical Focus

  • Pediatrics

Academic Appointments

Professional Education

  • Board Certification: American Board of Pediatrics, Pediatrics (2021)
  • Residency: UCLA Pediatric Residency (2020) CA
  • Medical Education: University of Texas Southwestern Medical School Registrar (2017) TX

Contact

  • Academic
    jtjose@stanford.edu
    University - Academic staff Department: Pediatrics - Cardiology Position: Clinical Instructor
  • Clinical Pediatric Cardiology 725 Welch Rd Ste 325 Palo Alto, CA 94304 (650) 725-8343 (fax)

Additional Info

All Publications

  • COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry. Pediatric cardiology Jose, J., Tierney, E. S., Harahsheh, A. S., Dahdah, N., Raghuveer, G., Friedman, K. G., Khoury, M., Hicar, M. D., Merves, S. A., Dallaire, F., Farid, P., Manlhiot, C., Runeckles, K., Misra, N., Portman, M., Ballweg, J. A., Lee, S., Jain, S. S., Harris, T. H., Szmuszkovicz, J. R., Orr, W., Larios, G., McCrindle, B. W. 2023: 1-9

    Abstract

    To determine clinical differences for children with complete Kawasaki disease (KD) with and without evidence of preceding SARS-CoV-2 infection. From January 2020, contemporaneous patients with complete KD criteria were classified as either SARS-CoV-2 positive (KDCOVID+; confirmed household exposure, positive PCR and/or serology) or SARS-CoV-2 negative (KDCOVID-; negative testing and no exposure) and compared. Of 744 patients in the International Kawasaki Disease Registry, 52 were KDCOVID- and 61 were KDCOVID+. KDCOVID+ patients were older (median 5.5 vs. 3.7 years; p < 0.001), and all additionally met diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C). They were more likely to have abdominal pain (60% vs. 35%; p = 0.008) and headache (38% vs. 10%; p < 0.001) and had significantly higher CRP, troponin, and BUN/creatinine, and lower hemoglobin, platelets, and lymphocytes. KDCOVID+ patients were more likely to have shock (41% vs. 6%; p < 0.001), ICU admission (62% vs. 10%; p < 0.001), lower left ventricular ejection fraction (mean lowest LVEF 53% vs. 60%; p < 0.001), and to have received inotropic support (60% vs. 10%; p < 0.001). Both groups received IVIG (2 doses in 22% vs. 18%; p = 0.63), but KDCOVID+ were more likely to have received steroids (85% vs. 35%; p < 0.001) and anakinra (60% vs. 10%; p = 0.002). KDCOVID- patients were more likely to have medium/large coronary artery aneurysms (CAA, 12% vs. 0%; p = 0.01). KDCOVID+ patients differ from KDCOVID-, have more severe disease, and greater evidence of myocardial involvement and cardiovascular dysfunction rather than CAA. These patients may be a distinct KD phenotype in the presence of a prevalent specific trigger.

    View details for DOI 10.1007/s00246-023-03109-w

    View details for PubMedID 36786810

    View details for PubMedCentralID PMC9926414

  • Outpatient monitoring of patients with multisystem inflammatory syndrome (MIS-C): A mini review. Frontiers in pediatrics Jose, J. T., Selamet Tierney, E. S. 2022; 10: 1069632

    Abstract

    As we learn more about the novel multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 infection, the protocols for long-term follow-up have evolved and only some of these protocols have been published. Here, we review the current literature on follow-up guidelines in MIS-C patients.We conducted a PUBMED search of all articles published on "MIS-C" and the term "follow-up" between 2020 and 2022. Inclusion criteria were that (1) the study was an observational study or case series, and (2) the study population included pediatric population who met the diagnostic criteria for MIS-C.There were 206 publications on MIS-C and follow-up in the last 2 years with 11 studies that fit the inclusion criteria. These papers were representing 11 different centers and encompassed a total of 343 participants. Seven of the 11 studies had participants follow-up with their cardiologist within 1 month of discharge. Between 12% and 62% of patients within each study had depressed left ventricular ejection fraction (LVEF) at admission. At the initial follow-up visit, five studies showed a normal LVEF in all patients while the other seven studies showed 2%-13% patients continuing to have depressed LVEF. In eight of the 11 studies, 9%-52% of patients had coronary artery dilation at admission. At their initial follow-up visit, 3%-28% of patients continued to have coronary artery dilation.There is some institutional variation in the outpatient follow-up protocols in patients diagnosed with MIS-C. A standardized follow-up guidelines might be helpful to monitor long-term prognosis of these patients.

    View details for DOI 10.3389/fped.2022.1069632

    View details for PubMedID 36568433

    View details for PubMedCentralID PMC9768426

https://orcid.org/0000-0001-5047-0893